Astera Labs (NASDAQ:ALAB) Shares Gap Down - Here's What Happened

Key Points

• Astera Labs shares fell sharply at Monday’s open, dropping from a previous close of $284.97 to $271.69 and last trading near $268.43.
• Analyst sentiment remains positive overall, with a consensus “Moderate Buy” rating and a $333 price target, although individual targets range from $153 to $297.
• The company recently exceeded quarterly earnings and revenue expectations, posting $0.80 EPS and $392.4 million in revenue, while insiders sold approximately $163.1 million worth of shares over the past three months.

Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report)'s share price gapped down before the market opened on Monday . The stock had previously closed at $284.97, but opened at $271.69. Astera Labs shares last traded at $268.4320, with a volume of 772,603 shares trading hands.

Analysts Set New Price Targets

A number of research firms recently weighed in on ALAB. Evercore reaffirmed an "outperform" rating and issued a $297.00 price objective on shares of Astera Labs in a research note on Tuesday, May 19th. Rothschild & Co Redburn began coverage on shares of Astera Labs in a report on Friday, May 1st. They set a "neutral" rating and a $153.00 target price on the stock. Weiss Ratings reissued a "hold (c)" rating on shares of Astera Labs in a research report on Tuesday, August 18th. Zacks Research upgraded shares of Astera Labs from a "hold" rating to a "strong-buy" rating in a report on Tuesday, August 11th. Finally, Citigroup reaffirmed a "buy" rating on shares of Astera Labs in a research report on Wednesday, July 29th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and eight have assigned a Hold rating to the company's stock. According to data from MarketBeat, Astera Labs currently has an average rating of "Moderate Buy" and a consensus target price of $333.00.

Astera Labs Stock Performance

The firm has a market capitalization of $48.08 billion, a PE ratio of 137.13 and a beta of 3.84. The stock has a fifty day moving average price of $352.70 and a 200-day moving average price of $245.57.

Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, topping analysts' consensus estimates of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The firm had revenue of $392.40 million during the quarter, compared to analysts' expectations of $360.85 million. During the same period in the prior year, the business posted $0.44 EPS. The firm's quarterly revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Research analysts expect that Astera Labs, Inc. will post 2.7 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, Director Jack R. Lazar sold 10,000 shares of Astera Labs stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $355.17, for a total value of $3,551,700.00. Following the transaction, the director owned 75,688 shares of the company's stock, valued at $26,882,106.96. The trade was a 11.67% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 90,630 shares of the business's stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the transaction, the chief operating officer owned 1,119,038 shares of the company's stock, valued at approximately $380,864,583.30. This trade represents a 7.49% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 419,244 shares of company stock valued at $163,135,169 in the last three months. 10.40% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Astera Labs

Several institutional investors have recently bought and sold shares of the company. California State Teachers Retirement System grew its stake in Astera Labs by 49,273.2% during the 2nd quarter. California State Teachers Retirement System now owns 100,158,544 shares of the company's stock worth $48,378,580,000 after buying an additional 99,955,684 shares during the last quarter. BlackRock Inc. purchased a new stake in Astera Labs in the second quarter valued at about $6,609,581,000. Bank of America Corp DE purchased a new stake in Astera Labs in the second quarter valued at about $1,061,791,000. Atreides Management LP raised its stake in Astera Labs by 108.9% in the first quarter. Atreides Management LP now owns 3,365,787 shares of the company's stock valued at $368,890,000 after buying an additional 1,754,593 shares during the last quarter. Finally, Amundi boosted its holdings in Astera Labs by 1,298.6% in the third quarter. Amundi now owns 1,421,263 shares of the company's stock worth $278,283,000 after acquiring an additional 1,319,643 shares in the last quarter. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source